AtriCure (ATRC) Cash from Financing Activities (2010 - 2026)

AtriCure (ATRC) has 17 years of Cash from Financing Activities data on file, last reported at -$13.3 million in Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$13.3 million, down 28.38% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.8 million (up 71.08% YoY), and the FY2025 annual result was $1.2 million, up 132.64% from the prior year.
• Cash from Financing Activities eased to -$13.3 million in Q1 2026 per ATRC's latest filing, from $2.1 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $6.0 million in Q3 2025 and troughed at -$13.3 million in Q1 2026.
• A 5-year average of -$1.3 million and a median of $1.7 million in 2024 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities plunged 352.27% in 2024, then soared 1897.0% in 2025.
• A 5-year view of Cash from Financing Activities shows it stood at $2.0 million in 2022, then grew by 19.02% to $2.4 million in 2023, then declined by 26.32% to $1.7 million in 2024, then climbed by 20.71% to $2.1 million in 2025, then slumped by 731.79% to -$13.3 million in 2026.
• Business Quant data shows ATRC's Cash from Financing Activities at -$13.3 million in Q1 2026, $2.1 million in Q4 2025, and $6.0 million in Q3 2025.